Equity Market Research
Wednesday, 5 August 2015
Alembic Pharmaceuticals: Expensive valuation restricts upside; downgrade to Neutral says Motilal Oswal Financial Services Ltd http://goo.gl/J3rEXo
Alembic Pharmaceuticals: Expensive valuation restricts upside; downgrade to Neutral says Motilal Oswal Financial Services Ltd http://goo.gl/J3rEXo
http://goo.gl/J3rEXo
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment